My watch list
my.chemeurope.com  
Login  

Norwegian Medicines Agency



The Norwegian Medicines Agency (Statens legemiddelverk, Legemiddelverket) is the national, regulatory authority for new and existing medicines and the supply chain. The Agency is responsible for supervising the production, trials and marketing of medicines. It approves medicines and monitors their use, and ensures cost-efficient, effective and well-documented use of medicines. The inspectorate also supervises the supply-chain and regulates prices and trade conditions for pharmacies.

Additional recommended knowledge

Sources

The Norwegian Medicines Agency



Public Hospital Trusts and State-Run Health Agencies in Norway

Norwegian Ministry of Health and Care Services

Government agencies
Board of Health Supervision | Directorate for Health and Social Affairs | Institute of Public Health | Medicines Agency

Hospital trusts of Northern Norway Regional Health Authority
Finnmark | Helgeland | Hålogaland | Nordland | Pharmaceutical Trust | University Hospital

Hospital trusts of Central Norway Regional Health Authority
Nordmøre and Romsdal | Nord-Trøndelag | Pharmaceutical Trust | St. Olav's | Sunnmøre

Hospital trusts of Western Norway Regional Health Authority
Bergen | Fonna | Førde | Stavanger | Pharmaceutical Trust

Hospital trusts of Southern and Eastern Norway Regional Health Authority
Aker | Akershus | New Akershus | Asker and Bærum | Blefjell | Buskerud | Innlandet | Pharmaceutical Trust | Pyschiatry of Vestfold | Rikshospitalet-Radiumhospitalet | Ringerike | Sunnaas | Southern Norway | Sykehuspartner | Telemark | Vestfold | Ullevål | Østfold

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Norwegian_Medicines_Agency". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE